Does regular sexual activity (regular ejaculation) reduce the risk of benign prostatic hyperplasia (BPH) or prostate cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Regular Sexual Activity Decrease Risk of BPH or Prostate Cancer?

Regular ejaculation appears to reduce prostate cancer risk, with higher ejaculation frequency (≥21 times per month) associated with approximately 30-50% risk reduction, but there is no established relationship between sexual activity and BPH risk.

Prostate Cancer Risk Reduction

Ejaculation Frequency - The Key Factor

The most robust evidence demonstrates that ejaculation frequency specifically—not sexual intercourse per se—is protective against prostate cancer. The landmark prospective Health Professionals Follow-up Study found that men reporting 21 or more ejaculations per month had significantly lower prostate cancer risk compared to those with 4-7 ejaculations monthly 1:

  • Ages 40-49 years: 32% risk reduction (RR 0.68)
  • Previous year: 51% risk reduction (RR 0.49)
  • Lifetime average: 33% risk reduction (RR 0.67)

A 2025 updated meta-analysis confirmed these findings, showing that higher ejaculation frequency demonstrated a significant protective effect (OR 0.83) 2. The 2018 dose-response meta-analysis further specified that moderate ejaculation frequency (2-4 times per week) was associated with 9% lower prostate cancer risk 3.

Early Adult Life Matters Most

Ejaculatory frequency during the third decade of life (ages 20-29) appears particularly important. Men averaging five or more ejaculations weekly in their 20s had 34% lower odds of prostate cancer (OR 0.66) compared to those ejaculating less frequently 4. This suggests the protective mechanism may involve long-term biological effects established early in life.

Mechanism of Protection

The protective effect likely relates to:

  • Clearance of potentially carcinogenic secretions from prostatic ducts
  • Reduction of intraprostatic carcinogen concentration through regular emptying
  • Hormonal regulation effects on prostatic tissue

Importantly, the number of sexual partners showed no association with prostate cancer risk (OR 1.01), arguing against sexually transmitted infections as a causative factor 2, 3.

BPH Risk - No Established Relationship

The provided guidelines and research evidence do not establish any relationship between sexual activity or ejaculation frequency and BPH development or progression. The 2003 AUA BPH Guidelines 5 make no mention of sexual activity as a risk factor or preventive measure for BPH. The 2026 review on modifiable BPH risk factors focused on physical activity and exercise but did not identify sexual activity as a relevant factor 6.

The AUA guidelines emphasize that BPH is primarily age-dependent, with prevalence exceeding 50% by age 60 and 90% by age 85, driven by hormonal changes rather than behavioral factors 5.

Clinical Implications

For Prostate Cancer Prevention

Counsel men that regular ejaculation (approximately 21+ times monthly or 2-4 times weekly) may reduce prostate cancer risk by 30-50%, with the greatest benefit when this pattern is established in early adulthood. This represents a low-risk, cost-free preventive strategy.

For BPH Management

Do not counsel patients that sexual activity will prevent or treat BPH. Focus instead on evidence-based interventions including alpha-blockers, 5-alpha-reductase inhibitors for enlarged prostates, and procedural options when indicated 5, 7, 8.

Important Caveats

  • The prostate cancer data come primarily from observational studies, though the prospective design of the Health Professionals Follow-up Study strengthens causality
  • Sexual dysfunction is a common adverse effect of BPH treatments (alpha-blockers cause ejaculatory dysfunction; 5-alpha-reductase inhibitors cause decreased libido, erectile dysfunction, and ejaculatory problems) 5
  • For prostate cancer survivors, sexual function recovery is important for quality of life but does not affect cancer outcomes 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.